Anzeige
Mehr »
Sonntag, 17.05.2026 - Börsentäglich über 12.000 News
China kontrolliert Antimon, eines der hochgradigsten Projekte der Welt?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A3D3BQ | ISIN: US28531P2020 | Ticker-Symbol: 43E0
Frankfurt
15.05.26 | 21:38
5,150 Euro
0,00 % 0,000
Branche
Gesundheitswesen
Aktienmarkt
Sonstige
1-Jahres-Chart
ELECTROCORE INC Chart 1 Jahr
5-Tage-Chart
ELECTROCORE INC 5-Tage-Chart

Aktuelle News zur ELECTROCORE Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MielectroCore, Inc.: electroCore Announces Publication in JAMA Highlighting the Benefits of Adding Quell Electrical Nerve Stimulation to Outpatient Physical Therapy in Fibromyalgia1
07.05.ElectroCore reaffirms 2026 revenue guidance of ~30% growth while targeting deeper VA utilization2
06.05.ElectroCore GAAP EPS of -$0.59 beats by $0.02, revenue of $9.6M beats by $0.59M2
ELECTROCORE Aktie jetzt für 0€ handeln
06.05.electroCore, Inc. - 10-Q, Quarterly Report-
29.04.electroCore, Inc.: electroCore to Announce First Quarter March 31, 2026, Financial Results on Wednesday, May 6, 20262
28.04.electroCore, Inc.: electroCore to Present at the Market Movers Investor Summit on May 5, 20262
23.04.electroCore, Inc.: electroCore Product Line Featured in Documentary Underscoring the Expanding Clinical and Commercial Role of Vagus Nerve Stimulation3
01.04.electroCore, Inc.: electroCore Announces Publication in Frontiers in Neuroscience Highlighting Benefits of Non-Invasive Vagus Nerve Stimulation in Patients with Mild Traumatic Brain Injury and PTSD1
31.03.electroCore, Inc.: electroCore Announces Inducement Grants under NASDAQ Listing Rule 5635(c)(4)1
20.03.electroCore stock maintained at Buy by H.C. Wainwright, $18 target1
20.03.ElectroCore outlines 30% revenue growth potential for 2026 as leadership transition advances1
19.03.Earnings Call Transkript: Electrocore meldet starkes Umsatzwachstum für Q4 20251
19.03.electroCore, Inc. - S-8, Securities to be offered to employees in employee benefit plans1
19.03.electroCore, Inc. - 10-K, Annual Report1
19.03.electroCore reports 27% revenue growth, CEO to retire1
19.03.ElectroCore GAAP EPS of -$1.65 beats by $0.07, revenue of $32.02M beats by $0.07M1
19.03.electroCore, Inc.: electroCore Announces Full Year 2025 Financial Results and Organizational Changes457Record full year 2025 net sales of $32.0, an increase of 27% over $25.2 million for the full year 2024 driven by 25% annual growth in our U.S. prescription business and 97% increase in general wellness...
► Artikel lesen
19.03.electroCore, Inc. - 8-K, Current Report1
18.03.ElectroCore FY Earnings Preview1
26.01.H.C. Wainwright lowers electroCore stock price target to $18 on higher expenses1
Weiter >>
28 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1